Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Travel Med Infect Dis ; 10(3): 157-61, 2012 May.
Artigo em Inglês | MEDLINE | ID: mdl-22521601

RESUMO

There are few data regarding microbiological findings from the disaster situation in Haiti. A rapid and accurate diagnosis of infection is necessary for the optimal efficacy of antimicrobial therapy, considering the antimicrobial spectrum and the duration of treatment. Furthermore, understanding the microorganisms and their susceptibility profiles is necessary to implement appropriate infection control policies and to contain the emergence and dissemination of Gram-negative multidrug-resistant pathogens.


Assuntos
Antibacterianos/uso terapêutico , Desastres , Farmacorresistência Bacteriana Múltipla/efeitos dos fármacos , Bactérias Gram-Negativas/efeitos dos fármacos , Infecções por Bactérias Gram-Negativas/tratamento farmacológico , Controle de Infecções/métodos , Feminino , Haiti , Humanos , Controle de Infecções/organização & administração , Masculino
2.
J Microbiol Methods ; 49(3): 295-300, 2002 May.
Artigo em Inglês | MEDLINE | ID: mdl-11869794

RESUMO

The purpose of this study was to evaluate the reliability of an amplification restriction analysis based method (hsp65-RFLP) to detect and identify mycobacterial species in clinical samples and cultures with low number of bacilli. We examined 247 clinical specimens and 88 culture vials, comparing hsp65-RFLP results with conventional culture/biochemical tests. The analytical sensitivity of the method was assessed with cerebrospinal fluid (CSF), broncho-alveolar lavage (BAL), sputum, water, and 12B medium containing defined amounts of mycobacterial chromosome. We detected the equivalent of 10(3) cells per ml in all samples, except sputum, the most common source of clinical sample for mycobacterial testing, which presented inhibition throughout. We investigated two purification procedures to overcome inhibition of DNA amplification: DNAzol and phenol/chloroform. The former was superior, eliminating inhibition in 93.7% of the clinical samples. The technique was effective for bacterial cultures, including those with very low growth indices (GIs), substantially abbreviating time for diagnosis, but showed low sensitivity (25%) when applied to clinical samples, an issue that has never been extensively assessed by other researchers.


Assuntos
Proteínas de Bactérias , Chaperoninas/genética , Infecções por Mycobacterium/diagnóstico , Mycobacterium/isolamento & purificação , Reação em Cadeia da Polimerase/métodos , Antígenos de Bactérias/genética , Técnicas de Tipagem Bacteriana , Líquido da Lavagem Broncoalveolar/microbiologia , Líquido Cefalorraquidiano/microbiologia , Chaperonina 60 , Clorofórmio , DNA/isolamento & purificação , Guanidina/farmacologia , Humanos , Mycobacterium/genética , Infecções por Mycobacterium/microbiologia , Fenol/farmacologia , Polimorfismo de Fragmento de Restrição , Sensibilidade e Especificidade , Especificidade da Espécie , Escarro/microbiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...